uOmnispace.MI vs ElucidVivo A.3

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

uOmnispace.MI

by United Imaging Healthcare (uOmnispace.MI)

ElucidVivo A.3

by Elucid

AI Verdict

uOmnispace.MI is a comprehensive medical imaging software offering broad 2D/3D viewing, AI-enhanced segmentation, and analysis across multiple modalities and clinical areas including cardiology, neurology, and oncology. ElucidVivo A.3, while also operating in cardiology AI, is a highly specialized tool focused specifically on AI-powered quantitative analysis of arterial plaque composition and stability from CT angiography for atherosclerosis patient stratification. Therefore, uOmnispace.MI is suitable for general advanced imaging analysis, while ElucidVivo A.3 is designed for detailed, specific cardiovascular plaque assessment.

Choose uOmnispace.MI if…

Choose uOmnispace.MI if your clinical practice requires a versatile, multi-modality imaging platform for comprehensive 2D and 3D analysis across oncology, neurology, and cardiology. This tool is ideal for institutions needing advanced AI-enhanced segmentation, fusion imaging, and dynamic PET data analysis for diverse diagnostic and research workflows.

View uOmnispace.MI →

Choose ElucidVivo A.3 if…

Choose ElucidVivo A.3 if your primary focus is on advanced, quantitative analysis of arterial plaque composition and stability from CT angiography to improve atherosclerosis patient stratification. This specialized AI-powered system is best suited for cardiovascular specialists seeking precise measurements of plaque characteristics, including LRNC and calcifications, to optimize treatment decisions.

View ElucidVivo A.3 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	uOmnispace.MI	ElucidVivo A.3
Deployment	Unknown	Cloud and on-premise secure deployment.
FDA Status	Unknown	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	uOmnispace.MI	ElucidVivo A.3
Company	Shanghai United Imaging Healthcare Co.	Elucid Bioimaging
Primary Clinical Focus	Supports clinical workflows in oncology, neurology, and cardiology.	Aids physicians in atherosclerosis patient stratification and optimizes treatment decisions for cardiovascular care.
Supported Imaging Modalities	PET, CT, MR, and SPECT images (DICOM).	CT angiography.
Key AI Capabilities	AI-enhanced segmentation (including AI-based rib extraction), image registration, lesion segmentation, quantitative analysis, dynamic PET data analysis.	AI-powered quantitative analysis of arterial plaque (Lipid-Rich Necrotic Core (LRNC), matrix, calcifications), 3D visualization of highlighted vessels, derivation of fractional flow reserve (FFRct).
Validation	Not specified	Validated on ground-truth histology

Videos

Demos, reviews, and walkthroughs featuring uOmnispace.MI and ElucidVivo A.3.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications and target specialties for each tool?

uOmnispace.MI is designed for comprehensive analysis across oncology, neurology, and cardiology, supporting specialties like nuclear medicine, oncology, and radiology. ElucidVivo A.3 is specialized for cardiovascular care, focusing on atherosclerosis patient stratification and optimizing treatment decisions within cardiology, radiology, and vascular surgery.

Which medical imaging modalities are supported by each software for analysis?

uOmnispace.MI provides comprehensive 2D and 3D viewing and analysis for PET, CT, MR, and SPECT images. ElucidVivo A.3 specifically performs quantitative analysis of arterial plaque composition and stability from CT angiography images.

What specific AI-powered analysis features differentiate these two tools?

uOmnispace.MI offers AI-enhanced segmentation, including features like AI-based rib extraction, along with manual and automatic segmentation tools. ElucidVivo A.3 provides AI-powered quantitative analysis of arterial plaque components such as Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications, and can derive fractional flow reserve (FFRct).

What kind of quantitative analysis does each tool offer, and how is its accuracy validated?

uOmnispace.MI offers general quantitative analysis, fusion imaging, and dynamic PET data analysis, with its rib labeling using deep learning algorithms validated on large datasets. ElucidVivo A.3 provides objective quantification of arterial plaque components and FFRct, with its plaque analysis validated against ground-truth histology.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform